Global Meningococcal Vaccines Market Research Report 2025(Status and Outlook)
Description
Report Overview
Meningococcal vaccines are designed to protect against infections caused by *Neisseria meningitidis*, a bacterium responsible for severe diseases such as meningitis and septicemia. These vaccines target various serogroups (A, B, C, W, Y, and X) and are available in polysaccharide and conjugate forms, with conjugate vaccines offering longer-lasting immunity and herd protection. The market is driven by rising awareness of meningococcal disease, government immunization programs, and increasing travel to high-risk regions. Key players include Pfizer, Sanofi, and GSK, with ongoing R&D focused on broader serogroup coverage and improved efficacy. Emerging markets show growth potential due to expanding healthcare infrastructure, though pricing pressures and regulatory hurdles remain challenges. The global market is expected to grow steadily, supported by outbreaks in certain regions and recommendations from health organizations.
The global Meningococcal Vaccines market size was estimated at USD 285.72 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.44% during the forecast period.
This report provides a deep insight into the global Meningococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccines market in any manner.
Global Meningococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
...
Market Segmentation (by Type)
Menactra
Menomune
Market Segmentation (by Application)
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccines Market
Overview of the regional outlook of the Meningococcal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Meningococcal vaccines are designed to protect against infections caused by *Neisseria meningitidis*, a bacterium responsible for severe diseases such as meningitis and septicemia. These vaccines target various serogroups (A, B, C, W, Y, and X) and are available in polysaccharide and conjugate forms, with conjugate vaccines offering longer-lasting immunity and herd protection. The market is driven by rising awareness of meningococcal disease, government immunization programs, and increasing travel to high-risk regions. Key players include Pfizer, Sanofi, and GSK, with ongoing R&D focused on broader serogroup coverage and improved efficacy. Emerging markets show growth potential due to expanding healthcare infrastructure, though pricing pressures and regulatory hurdles remain challenges. The global market is expected to grow steadily, supported by outbreaks in certain regions and recommendations from health organizations.
The global Meningococcal Vaccines market size was estimated at USD 285.72 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.44% during the forecast period.
This report provides a deep insight into the global Meningococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccines market in any manner.
Global Meningococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
...
Market Segmentation (by Type)
Menactra
Menomune
Market Segmentation (by Application)
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccines Market
Overview of the regional outlook of the Meningococcal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
134 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Meningococcal Vaccines
- 1.2 Key Market Segments
- 1.2.1 Meningococcal Vaccines Segment By Type
- 1.2.2 Meningococcal Vaccines Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Meningococcal Vaccines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Meningococcal Vaccines Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Meningococcal Vaccines Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Meningococcal Vaccines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Meningococcal Vaccines Product Life Cycle
- 3.3 Global Meningococcal Vaccines Sales By Manufacturers (2020-2025)
- 3.4 Global Meningococcal Vaccines Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Meningococcal Vaccines Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Meningococcal Vaccines Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Meningococcal Vaccines Market Competitive Situation And Trends
- 3.8.1 Meningococcal Vaccines Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Meningococcal Vaccines Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Meningococcal Vaccines Industry Chain Analysis
- 4.1 Meningococcal Vaccines Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Meningococcal Vaccines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Meningococcal Vaccines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Meningococcal Vaccines Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Meningococcal Vaccines Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Meningococcal Vaccines Sales Market Share By Type (2020-2025)
- 6.3 Global Meningococcal Vaccines Market Size Market Share By Type (2020-2025)
- 6.4 Global Meningococcal Vaccines Price By Type (2020-2025)
- 7 Meningococcal Vaccines Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Meningococcal Vaccines Market Sales By Application (2020-2025)
- 7.3 Global Meningococcal Vaccines Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Meningococcal Vaccines Sales Growth Rate By Application (2020-2025)
- 8 Meningococcal Vaccines Market Sales By Region
- 8.1 Global Meningococcal Vaccines Sales By Region
- 8.1.1 Global Meningococcal Vaccines Sales By Region
- 8.1.2 Global Meningococcal Vaccines Sales Market Share By Region
- 8.2 Global Meningococcal Vaccines Market Size By Region
- 8.2.1 Global Meningococcal Vaccines Market Size By Region
- 8.2.2 Global Meningococcal Vaccines Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Meningococcal Vaccines Sales By Country
- 8.3.2 North America Meningococcal Vaccines Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Meningococcal Vaccines Sales By Country
- 8.4.2 Europe Meningococcal Vaccines Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Meningococcal Vaccines Sales By Region
- 8.5.2 Asia Pacific Meningococcal Vaccines Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Meningococcal Vaccines Sales By Country
- 8.6.2 South America Meningococcal Vaccines Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Meningococcal Vaccines Sales By Region
- 8.7.2 Middle East And Africa Meningococcal Vaccines Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Meningococcal Vaccines Market Production By Region
- 9.1 Global Production Of Meningococcal Vaccines By Region(2020-2025)
- 9.2 Global Meningococcal Vaccines Revenue Market Share By Region (2020-2025)
- 9.3 Global Meningococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Meningococcal Vaccines Production
- 9.4.1 North America Meningococcal Vaccines Production Growth Rate (2020-2025)
- 9.4.2 North America Meningococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Meningococcal Vaccines Production
- 9.5.1 Europe Meningococcal Vaccines Production Growth Rate (2020-2025)
- 9.5.2 Europe Meningococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Meningococcal Vaccines Production (2020-2025)
- 9.6.1 Japan Meningococcal Vaccines Production Growth Rate (2020-2025)
- 9.6.2 Japan Meningococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Meningococcal Vaccines Production (2020-2025)
- 9.7.1 China Meningococcal Vaccines Production Growth Rate (2020-2025)
- 9.7.2 China Meningococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Glaxosmithkline
- 10.1.1 Glaxosmithkline Basic Information
- 10.1.2 Glaxosmithkline Meningococcal Vaccines Product Overview
- 10.1.3 Glaxosmithkline Meningococcal Vaccines Product Market Performance
- 10.1.4 Glaxosmithkline Business Overview
- 10.1.5 Glaxosmithkline Swot Analysis
- 10.1.6 Glaxosmithkline Recent Developments
- 10.2 Jn-international Medical
- 10.2.1 Jn-international Medical Basic Information
- 10.2.2 Jn-international Medical Meningococcal Vaccines Product Overview
- 10.2.3 Jn-international Medical Meningococcal Vaccines Product Market Performance
- 10.2.4 Jn-international Medical Business Overview
- 10.2.5 Jn-international Medical Swot Analysis
- 10.2.6 Jn-international Medical Recent Developments
- 10.3 Novartis International
- 10.3.1 Novartis International Basic Information
- 10.3.2 Novartis International Meningococcal Vaccines Product Overview
- 10.3.3 Novartis International Meningococcal Vaccines Product Market Performance
- 10.3.4 Novartis International Business Overview
- 10.3.5 Novartis International Swot Analysis
- 10.3.6 Novartis International Recent Developments
- 10.4 Sanofi
- 10.4.1 Sanofi Basic Information
- 10.4.2 Sanofi Meningococcal Vaccines Product Overview
- 10.4.3 Sanofi Meningococcal Vaccines Product Market Performance
- 10.4.4 Sanofi Business Overview
- 10.4.5 Sanofi Recent Developments
- 10.5 Pfizer
- 10.5.1 Pfizer Basic Information
- 10.5.2 Pfizer Meningococcal Vaccines Product Overview
- 10.5.3 Pfizer Meningococcal Vaccines Product Market Performance
- 10.5.4 Pfizer Business Overview
- 10.5.5 Pfizer Recent Developments
- 10.6 Baxter International
- 10.6.1 Baxter International Basic Information
- 10.6.2 Baxter International Meningococcal Vaccines Product Overview
- 10.6.3 Baxter International Meningococcal Vaccines Product Market Performance
- 10.6.4 Baxter International Business Overview
- 10.6.5 Baxter International Recent Developments
- 10.7 ...
- 10.7.1 ... Basic Information
- 10.7.2 ... Meningococcal Vaccines Product Overview
- 10.7.3 ... Meningococcal Vaccines Product Market Performance
- 10.7.4 ... Business Overview
- 10.7.5 ... Recent Developments
- 11 Meningococcal Vaccines Market Forecast By Region
- 11.1 Global Meningococcal Vaccines Market Size Forecast
- 11.2 Global Meningococcal Vaccines Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Meningococcal Vaccines Market Size Forecast By Country
- 11.2.3 Asia Pacific Meningococcal Vaccines Market Size Forecast By Region
- 11.2.4 South America Meningococcal Vaccines Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Meningococcal Vaccines By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Meningococcal Vaccines Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Meningococcal Vaccines By Type (2026-2033)
- 12.1.2 Global Meningococcal Vaccines Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Meningococcal Vaccines By Type (2026-2033)
- 12.2 Global Meningococcal Vaccines Market Forecast By Application (2026-2033)
- 12.2.1 Global Meningococcal Vaccines Sales (K Mt) Forecast By Application
- 12.2.2 Global Meningococcal Vaccines Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
